Vadivarhe Speciality Chemicals Complete Financial Statements
In FYNone, Vadivarhe Speciality Chemicals (VSCL) reported revenue ₹22 Cr, net profit ₹-10 Cr and EPS ₹-5.40, with a net profit margin of -23.7%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Vadivarhe Speciality Chemicals share price today.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
VSCL Revenue, Net Profit & EBITDA — Year-on-Year Growth
VSCL YoY (March 2025 vs Period) — revenue -42.1%, net profit -11.1%, expenses -36.4%.
VSCL Income Statement — Revenue, EBITDA & Net Profit
Vadivarhe Speciality Chemicals revenue ₹22 Cr, EBITDA ₹-6 Cr, net profit ₹-10 Cr, EPS ₹-5.40 (None) — net profit margin -23.7%. Explore VSCL value investing to estimate fundamental worth using multiple valuation models.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22 | 38 | 41 | 44 | 22 | 27 | 29 | 33 | 26 | 35 | 26 | 19 |
| Expenses | 28 | 44 | 36 | 40 | 28 | 27 | 38 | 30 | 22 | 25 | 19 | 12 |
| EBITDA | -6 | -6 | 5 | 4 | -7 | 0 | -9 | 3 | 4 | 11 | 8 | 8 |
| Operating Profit Margin % | -32.00% | -17.00% | 10.00% | 8.00% | -32.00% | -2.00% | -33.00% | 6.00% | 14.00% | 30.00% | 28.00% | 40.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 |
| Interest | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -10 | -9 | 2 | 1 | -10 | -3 | -12 | 0 | 2 | 10 | 5 | 5 |
| Tax | 0 | 0 | 1 | 0 | 0 | 0 | -2 | 0 | 0 | 3 | 1 | 0 |
| Net Profit | -10 | -9 | 0 | 1 | -10 | -3 | -10 | 0 | 2 | 6 | 4 | 5 |
| Earnings Per Share (₹) | -5.40 | -7.25 | 0.05 | 0.90 | -8.00 | -2.16 | -7.70 | 0.05 | 1.39 | 4.97 | 8.87 | 109.00 |
VSCL Balance Sheet — Assets, Liabilities & Shareholders' Equity
VSCL total assets ₹43 Cr, total equity ₹-3 Cr, total liabilities ₹43 Cr (2025).
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 43 | 42 | 46 | 42 | 47 | 51 | 58 | 44 | 46 | 33 | 28 |
| Current Assets | 20 | 18 | 20 | 14 | 19 | 21 | 23 | 16 | 22 | 13 | 12 |
| Fixed Assets | 22 | 22 | 23 | 24 | 26 | 25 | 26 | 20 | 17 | 14 | 15 |
| Capital Work in Progress | 0 | 2 | 1 | 1 | 0 | 3 | 2 | 2 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 20 | 19 | 22 | 16 | 21 | 23 | 30 | 23 | 29 | 19 | 13 |
| LIABILITIES | |||||||||||
| Total Liabilities | 43 | 42 | 46 | 42 | 47 | 51 | 58 | 44 | 46 | 33 | 28 |
| Current Liabilities | 23 | 19 | 17 | 17 | 15 | 11 | 16 | 7 | 7 | 7 | 9 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | -3 | 7 | 6 | 5 | 15 | 18 | 28 | 27 | 24 | 18 | 13 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 12 | 5 | 5 |
| Reserves & Surplus | -16 | -6 | -6 | -8 | 2 | 5 | 15 | 15 | 11 | 13 | 8 |
VSCL Cash Flow Statement — Operating, Investing & Financing
Vadivarhe Speciality Chemicals operating cash flow ₹-7 Cr, investing ₹-1 Cr, financing ₹9 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -7 | 2 | 0 | 1 | 0 | 4 | -1 | 7 | 2 | 3 | 5 |
| Investing Activities | -1 | -1 | -1 | -1 | 0 | -2 | -8 | -5 | -4 | -1 | 0 |
| Financing Activities | 9 | -2 | 1 | -1 | 1 | -2 | 9 | -1 | 2 | -3 | -4 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -1 | 1 |